Treats megaloblastic anemias due to folic acid deficiency. ANDA 89717, held by Hikma. Leucovorin Calcium.
As of Nov 16, 2026, ANDA 89717 (Leucovorin Calcium), held by Hikma, was first approved by FDA on Mar 28, 1988, with 13 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Leucovorin Calcium, USP rescue is indicated after high dose methotrexate therapy in osteosarcoma. Leucovorin Calcium, USP is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists. Leucovorin Calcium, USP is indicated in the treatment of megaloblastic anemias due to folic acid deficiency when oral therapy is not feasible. Leucovorin Calcium, USP is also indicated for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 28, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Leucovorin CalciumEQ 100MG BASE/VIAL · injectable;injection | Leucovorin Calcium | Rx |
| Dec 18, 2019 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jan 17, 2012 | Supplement 20Labeling | Approved | |
| Dec 4, 2000 | Supplement 12Manufacturing | Approved | None posted |
| Aug 3, 1998 | Supplement 11Labeling | Approved | None posted |
| Feb 24, 1998 | Supplement 10Labeling | Approved | None posted |
| May 31, 1996 | Supplement 9Labeling | Approved | None posted |
| Sep 25, 1995 | Supplement 8Manufacturing | Approved | None posted |
| Aug 8, 1995 | Supplement 2Manufacturing | Approved | None posted |
| Mar 21, 1994 | Supplement 7Manufacturing | Approved | None posted |
| Jun 2, 1993 | Supplement 6Labeling | Approved | None posted |
| Sep 2, 1992 | Supplement 1Manufacturing | Approved | None posted |
| Sep 2, 1992 | Supplement 5Manufacturing | Approved | None posted |
| Mar 11, 1991 | Supplement 4Labeling | Approved | None posted |
| Mar 28, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters